According to Protos, the Winklevoss-backed Zcash treasury company Cypherpunk Technologies reported a net loss of $37.8 million in the first half of 2026 and plans to shift more focus toward the anti-cancer drug Sirexatamab. The company currently holds 323,394 ZEC, approximately 1.92% of the circulating supply, valued at around $157 million, but the company’s overall market cap is only about $74 million. As of the end of June, cash and cash equivalents were just $7.6 million. https://(wublock123.com)/news/zcash-treasury-cypherpunk-37-8m-loss-shifts-to-anticancer-research-66437